Maintenance Dose of Magnesium Sulfate in Adults
For eclampsia/severe preeclampsia, use 1-2 g/hour IV continuous infusion as maintenance therapy after a 4-5 g loading dose, with 1 g/hour being equally effective and better tolerated than 2 g/hour. 1
Clinical Context-Specific Dosing
Eclampsia and Severe Preeclampsia (Primary Indication)
The FDA-approved maintenance regimen offers two options 1:
- Standard maintenance: 4-5 g IM every 4 hours into alternate buttocks
- Preferred IV maintenance: 1-2 g/hour by continuous infusion
Recent evidence strongly favors the 1 g/hour regimen over 2 g/hour. A 2026 systematic review of randomized trials demonstrated that 1 g/hour maintenance is equally effective at preventing eclampsia (0.76% vs 0.57% incidence, OR 1.33,95% CI: 0.18-9.60) but causes significantly fewer maternal side effects (22% vs 67%, OR 7.05,95% CI: 4.22-11.78) 2. When directly comparing the two maintenance doses, no eclampsia occurred with either regimen, but side effects remained significantly higher with 2 g/hour (71% vs 42%, OR 1.69,95% CI: 1.06-2.71) 2.
Critical safety parameters:
- Target serum magnesium: 6 mg/100 mL (optimal for seizure control) 1
- Maximum daily dose: 30-40 g over 24 hours 1
- Continue until paroxysms cease 1
- Monitor patellar reflexes and respiratory function before each IM dose 1
Torsades de Pointes
For drug-induced TdP with prolonged QT, give 2 g IV bolus as first-line therapy, repeating as needed if episodes persist 3. This is a Class IIa recommendation (Level of Evidence: B) and should be administered regardless of serum magnesium level 3. The mechanism remains unknown but is clinically effective 3.
Magnesium Deficiency States
Maintenance dosing varies by severity 1:
- Mild deficiency: 1 g IM every 6 hours for 4 doses (total 32.5 mEq/24 hours)
- Severe hypomagnesemia: 5 g (40 mEq) added to 1 L D5W or NS, infused over 3 hours
- TPN maintenance: 8-24 mEq (1-3 g) daily in adults; 2-10 mEq (0.25-1.25 g) daily in infants
Other Indications
- Seizures (epilepsy, glomerulonephritis, hypothyroidism): 1 g IM or IV 1
- Paroxysmal atrial tachycardia: 3-4 g IV over 30 seconds (use only if simpler measures fail and no myocardial damage) 1
- Barium poisoning: 1-2 g IV 1
Critical Safety Considerations
Renal Impairment
In severe renal insufficiency, maximum dose is 20 g/48 hours with mandatory frequent serum magnesium monitoring 1. Caution is essential to avoid exceeding renal excretory capacity 1.
Pregnancy-Specific Warning
Do not continue magnesium sulfate beyond 5-7 days in pregnancy—prolonged use causes fetal abnormalities 1. This is a critical pitfall frequently overlooked in clinical practice.
Administration Rate
IV injection rate should not exceed 150 mg/minute (1.5 mL of 10% solution), except in severe eclampsia with active seizures 1. Solutions must be diluted to ≤20% concentration before IV infusion 1.
Monitoring Requirements
- Patellar reflexes (must be present before each dose)
- Respiratory rate (>12-16/min)
- Urine output (>25-30 mL/hour)
- Serum magnesium levels in renal impairment
Route Selection
IV administration is preferred over IM when feasible 4. A 2024 randomized trial (n=496) demonstrated that IV infusion via pump was significantly more acceptable than IM administration (95.3% vs 70.3%, p<0.001) with lower median pain scores (2 vs 4, p<0.001) and fewer side effects, while maintaining comparable maternal mortality (0.8% vs 1.2%) 4.
IM administration produces therapeutic levels in 60 minutes, while IV provides immediate therapeutic levels 1.
Common Pitfalls
- Using 2 g/hour maintenance routinely: The lower 1 g/hour dose is equally effective with better tolerability 2
- Forgetting renal dose adjustment: Failure to reduce dosing in renal insufficiency risks toxicity 1
- Prolonged use in pregnancy: Beyond 5-7 days causes fetal harm 1
- Inadequate dilution: Concentrations >20% for IV use increase adverse effects 1
- Missing drug interactions: Magnesium reduces antibiotic activity of streptomycin, tetracycline, and tobramycin 1